Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Danner

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Genitourinary Medicine|December 1, 1990
Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infectionR van Leeuwen, P J van den Hurk, G J Jöbsis, et al.
British Medical Journal (Clinical Research Ed.)|December 6, 1986
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDSJ M Lange, D A Paul, H G Huisman, et al.
European Journal of Respiratory Diseases|May 1, 1986
Gallium-67 lung scintigraphy in patients with acquired immune deficiency syndrome (AIDS)S C Reinders Folmer, S A Danner, A J Bakker, et al.
Nature Medicine|February 14, 1998
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferationN G Pakker, D W Notermans, R J de Boer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapyN M Ferguson, F deWolf, A C Ghani, et al.
AIDS (London, England)|April 19, 2000
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study GroupE H Gisolf, S Jurriaans, J Pelgrom, et al.
Blood|July 13, 2000
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapyD R Clark, S Repping, N G Pakker, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
The Netherlands Journal of Medicine|January 1, 1985
AIDS in The Netherlands. Clinical and microbiological data on 36 casesS A Danner, J M Lange, J W Van der Meer, et al.
AIDS (London, England)|January 12, 2001
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infectionM den Brinker, F W Wit, P M Wertheim-van Dillen, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Genitourinary Medicine|December 1, 1990
Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infectionR van Leeuwen, P J van den Hurk, G J Jöbsis, et al.
British Medical Journal (Clinical Research Ed.)|December 6, 1986
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDSJ M Lange, D A Paul, H G Huisman, et al.
European Journal of Respiratory Diseases|May 1, 1986
Gallium-67 lung scintigraphy in patients with acquired immune deficiency syndrome (AIDS)S C Reinders Folmer, S A Danner, A J Bakker, et al.
Nature Medicine|February 14, 1998
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferationN G Pakker, D W Notermans, R J de Boer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapyN M Ferguson, F deWolf, A C Ghani, et al.
AIDS (London, England)|April 19, 2000
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study GroupE H Gisolf, S Jurriaans, J Pelgrom, et al.
Blood|July 13, 2000
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapyD R Clark, S Repping, N G Pakker, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
The Netherlands Journal of Medicine|January 1, 1985
AIDS in The Netherlands. Clinical and microbiological data on 36 casesS A Danner, J M Lange, J W Van der Meer, et al.
AIDS (London, England)|January 12, 2001
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infectionM den Brinker, F W Wit, P M Wertheim-van Dillen, et al.
Pageof 15